Katja Sladko

Katja Sladko is an experienced professional in clinical quality assurance and clinical research, currently serving as Associate Director of Clinical Quality Assurance at Molecular Partners AG in Zurich, Switzerland, since October 2016. With a strong background in maintaining efficient quality systems compliant with GCP and regulatory requirements, Katja has expertise in document review, deviation management, vendor compliance, and auditing. Prior roles include GxP Consultant at RQM GMP-Consulting GmbH, where responsibilities included process improvement and compliance management, and Clinical Research Manager at Astellas Pharma AG, overseeing late-phase clinical trials across various therapeutic areas. Earlier experience includes serving as a Clinical Study Manager at Grünenthal and as a Research Assistant in preclinical research at Cytos biotechnology AG. Katja holds a degree in Biochemistry and Molecular Biology from the University of Bayreuth, Germany, earned in 2001.